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Aim: To compare the immediate antibacterial effect of two application methods (passive
immersion and active mouthwash) of two antiseptic solutions on the in situ oral biofilm.
Material and Methods: A randomized observer-masked crossover study was
conducted. Fifteen healthy volunteers wore a specific intraoral device for 48 h to form
a biofilm in three glass disks. One of these disks was used as a baseline; another one
was immersed in a solution of 0.2% Chlorhexidine (0.2% CHX), remaining the third in the
device, placed in the oral cavity, during the 0.2% CHX mouthwash application. After
a 2-weeks washout period, the protocol was repeated using a solution of Essential
Oils (EO). Samples were analyzed for bacterial viability with the confocal laser scanning
microscope after previous staining with LIVE/DEAD® BacLight™.
Results: The EO showed a better antibacterial effect compared to the 0.2% CHX after
the mouthwash application (% of bacterial viability = 1.16 ± 1.00% vs. 5.08 ± 5.79%,
respectively), and was more effective in all layers (p < 0.05). In the immersion, both
antiseptics were significantly less effective (% of bacterial viability= 26.93± 13.11%, EO
vs. 15.17 ± 6.14%, 0.2% CHX); in the case of EO immersion, there were no significant
changes in the bacterial viability of the deepest layer in comparison with the baseline.
Conclusions: The method of application conditioned the antibacterial activity of the
0.2% CHX and EO solutions on the in situ oral biofilm. The in vivo active mouthwash was
more effective than the ex vivo passive immersion in both antiseptic solutions. There was
more penetration of the antiseptic inside the biofilm with an active mouthwash, especially
with the EO. Trial registered in clinicaltrials.gov with the number NCT02267239. URL:
https://clinicaltrials.gov/ct2/show/NCT02267239.
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Introduction
The use of oral antiseptics is a recommended procedure for the chemical control of the oral
biofilms. These oral antiseptics may kill the microorganisms, reduce bacterial virulence, and retard
the dental plaque formation. Due to this action on the bacteria forming dental biofilms, a reduction
of the oral disease is expected after their application (Corbin et al., 2011).
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Among dental practitioners, the most commonly prescribed
oral antiseptics have been those including in their formulation
Chlorhexidine (CHX) (Varoni et al., 2012) or Essential Oils
(EO) (Axelsson, 2004). Although the antimicrobial effectiveness
of both has been shown in previous studies (Gunsolley, 2010;
Quintas et al., 2015), they exhibit different traits when certain
methodologies are followed, which, in some cases, may limit
the reliability of the results. Some of these differences have been
recognized by the scientific community, who cautiously interpret
the results of the studies that have used an in vitro-formed biofilm
(Auschill et al., 2004). The use of determinate bacteria to create
a biofilm in an artificial environment may result in a measure of
antiseptic effectiveness that may not be representative of the in
situ situation (Auschill et al., 2005).
Bacteria living in dental plaque develop relationships forming
an extracellular matrix which is a highly resistant three-
dimensional (3-D) structure. This association makes the biofilm
bacteria from 10 to 1000 times more resistant to an antiseptic
(Fine et al., 2001; Davies, 2003). Given this, the handling of
the in situ formed biofilm is an important characteristic that
studies involving oral biofilms should take into account. In
some studies the 3-D structure of the oral biofilm is altered
when the sample is collected (Pan et al., 2000; Fine et al.,
2005) or during the analysis process (Jentsch et al., 2002; Vitkov
et al., 2005). The distortion of the 3-D structure probably
influences the quantification of the antiseptic effectiveness. To
avoid this, specific oral devices have been designed to allow
the formation of a non-disturbed biofilm, similar to the dental
plaque, which has been called plaque-like biofilm (PL-biofilm)
(Prada-López et al., 2015a; Quintas et al., 2015). Furthermore, the
use of confocal laser scanning microscope (CLSM) has allowed
the possibility to analyse the in situ biofilm in their natural
hydrated state without losing its complex structure (Arweiler
et al., 2004). The CLSM has been used in combination with
dual live/dead staining solutions. This has given to investigators
the possibility to analyse the viability of a non-disturbed in situ
oral biofilm, before and after the application of the antiseptics.
Among the different available staining solutions, the SYTO 9
and propidium iodide has been one of the most successfully
employed combinations of fluorochromes for visualizing dental
plaque (Fuchslocher Hellemann et al., 2013; Hannig et al., 2013;
Tawakoli et al., 2013; Prada-López et al., 2015a; Quintas et al.,
2015).
Recently, some authors have stated that the methodology of
the application of a given antiseptic could be an important factor
which might condition the results on oral antiseptic effectiveness
(Quintas et al., 2015). Commonly, in studies with undisturbed
biofilm, the application of the antiseptic has been an ex vivo
immersion of the sample into the solution (Zaura-Arite et al.,
2001; Dong et al., 2010; Gosau et al., 2010; von Ohle et al., 2010).
However, in recent series about the bacterial effect of CHX and
EO, the participants have undergone an active mouthwash with
Abbreviations: 0.2% CHX, solution of 0.2% of Chlorhexidine; EO, Essential Oils;
PL-biofilm, plaque-like biofilm; IDODS, intraoral device of overlaid disk-holding
splints; Im-0.2%CHX, immersion in 0.2% Chlorhexidine; Im-EO, immersion in
Essential Oils; Mw-0.2%CHX, mouthwash with 0.2% Chlorhexidine; Mw-EO,
mouthwash with Essential Oils.
the antiseptic in vivo (García-Caballero et al., 2013; Quintas et al.,
2015), differing from the previously described results, mainly in
regard to the EO activity.
Based on these previous findings, the authors of the present
study intended to assess if the methodology of the antiseptic
application might condition the obtained results in terms of
bacterial viability of the PL-biofilm. Therefore, the objective of
the present study was to compare the immediate effect of two
antiseptic application methods, using separate solutions of 0.2%
CHX and EO applied either by a passive immersion or an active
mouthwash (ex vivo vs. in vivo exposure).
Material and Methods
The present study was designed as a randomized, observer-
masked, crossover study. The immediate effect of 0.2% CHX
and EO solutions was tested using them separately in immersion
and mouthwash application on an in situ model of PL-biofilm
growth. The supporting CONSORT checklist is available as
supporting information (supplementary Table 1). This project
got the approval of the Clinical Research Ethics Committee of
Galicia (number 2012/393) and registered in clinicaltrials.gov
with the number NCT02267239. URL: https://clinicaltrials.gov/
ct2/show/NCT02267239.
Selection of the Study Group
To calculate an a priori sample size, the following statistical
criteria were established: an effect size of 0.35, an alpha error of
0.05 and a statistical power of 87%. Assuming these criteria and
using the repeated measures ANOVA test, a sample size of 15
subjects was required. The sample size calculation was performed
using the program G*Power 3.1.5. The participants were
recruited among dental students at the Faculty of Medicine and
Dentistry of Santiago de Compostela (Spain), where volunteer
enrolment was asked by responding to advertisements for the
participation in a research study at the faculty hall. All of these
volunteers were revised by the same trained clinician to ensure
they fulfilled all inclusion and exclusion criteria. The volunteers
chosen met the same inclusion and exclusion criteria of previous
publications of our group (García-Caballero et al., 2013; Prada-
López et al., 2015a; Quintas et al., 2015). The inclusion criteria
were the following: being systemically healthy adult volunteers
between 20 and 45 years old, who presented a good oral health
status: a minimum of 24 permanent teeth with no evidence
of gingivitis or periodontitis (Community Periodontal Index
score = 0) (WHO, 1997) and an absence of untreated caries
at the beginning of the study. The following exclusion criteria
were applied: smoker or former smoker, presence of dental
prostheses or orthodontic devices, antibiotic treatment or routine
use of oral antiseptics in the previous 3 months, and presence
of any systemic disease that could alter the production or
composition of saliva. Before the start of each phase, a full mouth
scaling with ultrasonic instruments and teeth polishing with
rubber cup after dental disclosure was performed by the same
trained clinician on all selected participants (Figure 1). Written
informed consent was obtained from all participants in the
study.
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FIGURE 1 | Protocol of the study.
Intraoral Device of Overlaid Disk-Holding Splints
(IDODS) for Biofilm in Situ Formation
Some in situ models for the growth of the biofilm have been
previously described (Netuschil et al., 1998; Auschill et al.,
2001, 2005; Arweiler et al., 2004). After their consideration,
an individualized splint of a lower hemi-arch was created for
each volunteer, following the same protocol given in previous
studies (García-Caballero et al., 2013; Prada-López et al., 2015a,b;
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Quintas et al., 2015). The Intraoral Device of Overlaid Disk-
holding Splints (IDODS) worn by the volunteers held three glass
disks (6mm in diameter, 1mm thickness); these were polished
at 800 grit. This splint has been already described in previous
own works (Prada-López et al., 2015a,b; Quintas et al., 2015)
(Figure 2).
The IDODS with the glass disks was worn by the subjects
for 48 h (2 days) to favor growth of the PL-biofilm. They
were allowed to withdraw it from the oral cavity only during
meals and to perform oral hygiene measures (while it had to
be stored in a previously provided opaque container in humid
conditions). In order to not to disturb the growing of the PL-
biofilm, volunteers could not use any toothpaste or mouthwash
as a complement for the mechanical removal of bacterial
plaque.
Application of the 0.2% CHX and EO to
PL-Biofilm
The sample analysis was divided into two phases, each of
following the application protocol of the antiseptic. The first
consisted of withdrawing the glass disks one by one from the
splint (Figure 1) after the volunteer had worn it for 48 h. The
distal of these disks was used as a baseline sample. The second
disk underwent one of two protocols:
A single, 30-s immersion in 1mL of 0.2% Chlorhexidine
(Oraldine Perio R©, Johnson & Johnson, Madrid, Spain) (Im-0.2%
CHX).
-OR-
A single, 30-s immersion in 1mL of Essential Oils in a
hydroalcoholic solution (Listerine Mentol, Listerine R©, Johnson
& Johnson, Madrid, Spain) (Im-EO).
Next, the second phase of the study was conducted.
The last disk in the splint, placed in the oral cavity, was
withdrawn after the volunteer performed the following under
supervision:
FIGURE 2 | Intraoral view of the Intraoral Device Overlaid Disk-holding
Splint (IDODS).
A single, 30-s mouthwash with 10mL of 0.2% Chlorhexidine
(Oraldine Perio R©, Johnson & Johnson, Madrid, Spain)
(Mw-0.2% CHX), following the instructions of the manufacturer.
-OR-
A single, 30-s mouthwash with 20mL of Essential Oils in a
hydroalcoholic solution (Listerine Mentol, Listerine R©, Johnson
& Johnson, Madrid, Spain) (Mw-EO), following the instructions
of the manufacturer.
Using an internet-based balanced randomization system
(www.randomization.com) that indicated the antiseptic each
subject would use first and second, as well as the hemi-arch (left
or right) selected for the immersion and mouthwash. All subjects
performed the two tests with a rest period of 14 days in-between
(Figure 1).
Collection of the Samples of PL-Biofilm
On the day of the experiment, the volunteers were not allowed
to eat or drink during the course of the tests. PL-biofilm samples
collection was done individually (samples were taken from just
one volunteer per day), starting at 8.30 AM (first baseline sample
and immersions) and finished at 9.30 AM (mouthwash).
Immediately after the glass disks were withdrawn from the
splints, they were submerged in 100µL of fluorescence solution
LIVE/DEAD R© BacLight™ and kept in a dark chamber at room
temperature for 15min. A single investigator, masked to the
study design, performed the microscopic observation using a
Leica TCS SP2 laser scanning spectral confocal microscope (Leica
Microsystems Heidelberg GmbH, Mannheim, Germany) with an
HCX APOL 63x/0.9 water-immersion lens.
Processing of the PL-Biofilm Samples
In the present series, the same protocol described by Quintas
et al. (2015) was followed to evaluate the different fields within
the disks. Four selected fields (considered as representative of the
whole sample), which were in the central part of each disk were
evaluated; their mean measures of the thickness and bacterial
viability represented the whole sample thickness and bacterial
viability, respectively. The maximum biofilm thickness of each
field was divided into three equivalent zones or same sized layers:
outer layer (layer 1), middle layer (layer 2) and inner layer
(layer 3).
The capture of the data was done with the same settings in
all cases, according to previously presented parameters (Quintas
et al., 2015) (Figure 3).
Quantification of bacterial viability was also done as
previously presented (Quintas et al., 2015) using the
cytofluorographic analysis (Leica Confocal Software) of XY
images. In this analysis, the images of each fluorochrome were
defined as “channels” (SYTO 9 occupies the green channel and
propidium iodide the red channel). Square capture masks were
used to measure the area occupied (µm2) by the pixels in each
channel, determining the total area occupied by the biofilm and
the corresponding percentage of viability. The intensity range
was considered a positive signal if it was between 100 and 255.
Determination of the mean percentage of bacterial viability in
each field required sections with a minimum area of biofilm of
250µm2; the mean percentage of bacterial viability of the biofilm
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FIGURE 3 | Representative images of the PL-biofilm (“stacked
projection” of images in the “Z” axis) bacterial viability under basal
conditions, after immersion and after mouthwash with 0.2%
Chlorhexidine and Essential Oils. (They are images of representative fields
of the PL-biofilm. It is a maximum projection of all obtained images in the
plane XY in the Z axis for a same field. That is commonly called “stacked
projection.” These images do not represent nor the outer, the middle or the
inner layers, they represent all of them projected in the same axis).
was calculated for the corresponding sample and for each biofilm
layer.
Statistical Analysis
The data on thickness and bacterial viability in the PL-biofilm,
were expressed as mean and standard deviation of the mean.
The type of distribution of the quantitative variables analyzed
was determined using the Kolmogorov–Smirnov test, obtaining
a normal distribution for all values. Repeated measures ANOVA
test and pairwise comparisons (with the Bonferroni correction)
were used for the analysis of intra- and inter-application
results for 0.2% CHX and EO and inter-antiseptic solution
results (including differentiating between the 3 biofilm layers).
Measurements were statistical significant if the p value less
than 0.05. The statistical analysis was performed by the PASW
Statistics Base 20 package for Windows (IBM, Madrid, Spain).
Results
Influence of the Application of Methods of 0.2%
CHX and EO on the PL-Biofilm Thickness
The thicknesses obtained in both baseline disks were 19.17 and
20.33µm, before applying either 0.2% CHX or EO, respectively.
After the Im-0.2% CHX, the thickness was 17.64µm and
15.77µm after the mouthwash. When the applied antiseptic
was the EO, the obtained thicknesses were 17.97 and 20.82µm,
after immersion and mouthwash, respectively. No significant
differences were found in either case.
Influence of the Application Methods of 0.2%
CHX and EO on the PL-Biofilm Bacterial Viability
The bacterial viability in the baseline disks was not significantly
different between the two series of 0.2% CHX and the EO
(72.21± 10.48% vs. 75.72± 14.33%).
After the Im-0.2% CHX, the bacterial viability was
significantly reduced to 15.17 ± 6.14%. In contrast, the
bacterial viability after the Mw-0.2% CHX was 5.08 ± 5.79%
(Figure 4), which was significantly lower than the Im-0.2% CHX
(p = 0.001). In addition, both results differed significantly from
their baseline values (p < 0.001) (Table 1).
In the same way, the Im-EO significantly reduced the bacterial
viability to 26.93± 13.11%. However, after Mw-EO, the bacterial
viability was reduced to 1.16 ± 1.00% (Figure 5), which was
significantly lower than the Im-EO (p < 0.001). Besides, both
results differed significantly from their baseline values (p <
0.001) (Table 1).
In the comparison of the two antiseptics, the Im-0.2% CHX
obtained significantly lower values of bacterial viability compared
with the Im-EO (15.17 ± 6.14% CHX vs. 26.93 ± 13.11% EO,
p < 0.05). On the other hand, the Mw-EO achieved significantly
lower bacterial viability in comparison with the Mw-0.2% CHX
(1.16± 1.00% vs. 5.08± 5.79%, p < 0.05) (Table 2).
Influence of the Application Methods of CHX and
EO on the PL-Biofilm Bacterial Viability by Layers
When accounting for the different layers, the values for baseline
bacterial viability decreased progressively for deeper layers
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FIGURE 4 | Total bacterial viability and by PL-biofilm layers in the 0.2% Chlorhexidine series. (PL-biofilm, plaque like-biofilm; 0.2% CHX, 0.2% of
Chlorhexidine; CLSM, confocal laser scanning microscope).
TABLE 1 | Inter-application analysis for 0.2% of Chlorhexidine and
Essential Oils by layers.
Application method 0.2% Chlorhexidine Essential
(inter-application) Oils
TOTAL
Baseline vs. immersion p < 0.001 p < 0.001
Baseline vs. mouthwash p < 0.001 p < 0.001
Immersion vs. mouthwash p = 0.001 p < 0.001
LAYER 1
Baseline vs. immersion p < 0.001 p < 0.001
Baseline vs. mouthwash p < 0.001 p < 0.001
Immersion vs. mouthwash p = 0.001 p = 0.002
LAYER 2
Baseline vs. immersion p < 0.001 p < 0.001
Baseline vs. mouthwash p < 0.001 p < 0.001
Immersion vs. mouthwash p = 0.001 p < 0.001
LAYER 3
Baseline vs. immersion p < 0.001 –
Baseline vs. mouthwash p < 0.001 p < 0.001
Immersion vs. mouthwash p = 0.046 p < 0.001
(baseline sample prior to 0.2% CHX application in layer 1 =
83.91 ± 9.51%, layer 2 = 78.26 ± 9.93%, and layer 3 = 54.46 ±
25.43% (Figure 4 and Table 3); baseline sample prior to EO
application in layer 1= 89.53± 8.34%, layer 2= 82.12± 13.26%,
and layer 3= 55.53± 28.19%) (Figure 5 and Table 3).
After the Im-0.2% CHX protocol, the sample showed a
homogeneous decrease in value from the baseline situation in all
layers (Im-0.2% CHX, layer 1= 17.90± 9.16%, layer 2= 16.23±
7.14%, and layer 3 = 11.38 ± 5.81%, p < 0.001 in all cases). In
addition, after the Mw-0.2% CHX protocol, the bacterial viability
was more reduced compared to the immersion protocol (Mw-
0.2% CHX, layer 1= 5.22± 6.16%, layer 2= 5.04± 6.40%, layer
3 = 4.97 ± 5.00%, p < 0.05 comparing Im-0.2% CHX and its
baseline) (Figure 4 and Table 1).
After the Im-EO protocol, the sample showed a general
decrease from the baseline disk in the superficial layers (Im-
EO, layer 1 = 16.18 ± 12.38% and layer 2 = 25.60 ± 14.51%,
p < 0.001 in layers 1 and 2) but not in the deepest layer (Im-
EO, layer 3 = 39.02 ± 17.50%). In contrast, the results after the
Mw-EO showed a highly reduced bacterial viability in all layers of
the PL-biofilm, thus it was significantly more effective at reducing
bacterial viability than the immersion protocol (Mw-EO, layer 1
= 1.62± 1.54%, layer 2 = 1.12 ± 1.16%, and layer 3 = 0.72 ±
0.56%; p < 0.05 comparing Im-EO and its baseline) (Figure 5
and Table 1).
Comparing the two antiseptics, although both showed a
significant reduction of bacterial viability after immersion in all
layers, in layer 3 the 0.2% CHX solution showed more reduced
bacterial viability than did the EO (layer 3, Im-0.2% CHX vs. Im-
EO, 11.38 ± 5.81% vs. 39.02 ± 17.50%; p < 0.001). In contrast,
in comparison with the mouthwash application, the Mw-EO
obtained lower bacterial viability than the Mw-0.2% CHX, in all
layers (p < 0.05) (Table 2).
Discussion
To the best of the author’s knowledge, there are no published
studies which compare the immediate antibacterial effect of an
oral antiseptic applied using the two methods referred to in
much of the literature (ex vivo passive immersion and in vivo
active mouthwash) within the same experiment (using the same
volunteer and PL-biofilm within one growth period).
In the present series, glass disks were used instead of enamel
ones for several reasons. The first, and more important, is that
previous research (Netuschil et al., 1998) and own’s (unpublished
data) revealed that there were no significant differences in the
bacterial viability and thickness of the 2-day PL-biofilm formed
on enamel or polished glass analyzed with CLSM. This is a very
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FIGURE 5 | Total bacterial viability and by PL-biofilm layers in the Essential Oils series. (PL-biofilm, plaque like-biofilm; EO, Essential Oils; CLSM, confocal
laser scanning microscope).
TABLE 2 | Inter-antiseptic solution analysis between 0.2% of
Chlorhexidine and Essential Oils by layers.
Application method 0.2% Chlorhexidine vs.







Total p = 0.007
Layer 1 –
Layer 2 –
Layer 3 p < 0.001
MOUTHWASH
Total p = 0.020
Layer 1 p = 0.041
Layer 2 p = 0.034
Layer 3 p = 0.006
important fact because it is much easier to obtain a regular glass
disk in size and thickness than from enamel, being this crucial
to the construction of the intraoral splints and the stability of
the disks into it. Another reason is the difficulty of analysing the
biofilm formed on an enamel disk due to the irregularity (it is not
a plane surface) giving distorted images at the CLSM. In addition,
although the sterility of the enamel disks could be achieved easily,
there always could exist the latent risk of prion diseases, which
would bring an important moral dilemma.
PL-biofilm Thickness
The present series showed a constant thickness of the PL-biofilm
after all applied situations. The application of the antiseptic,
either by immersion or mouthwash, did not change the basal
TABLE 3 | Intra-application analysis for 0.2% of Chlorhexidine and
Essential Oils by layers.
Application method 0.2% Chlorhexidine Essential
(intra-application) Oils
BASELINE
Layer 1 vs. Layer 2 p = 0.038 p = 0.021
Layer 1 vs. Layer 3 p = 0.005 p = 0.001
Layer 2 vs. Layer 3 p = 0.006 p = 0.001
IMMERSION
Layer 1 vs. Layer 2 – p = 0.004
Layer 1 vs. Layer 3 – p < 0.001
Layer 2 vs. Layer 3 – p < 0.001
MOUTHWASH
Layer 1 vs. Layer 2 – p = 0.021
Layer 1 vs. Layer 3 – –
Layer 2 vs. Layer 3 – –
thickness. The previous literature support this situation, no
matter the antiseptic solution or the methodology of application
used in the studies (Zaura-Arite et al., 2001; Dong et al., 2010;
von Ohle et al., 2010; García-Caballero et al., 2013; Quintas et al.,
2015), so that a single application of 0.2% CHX or EO does not
affect the thickness of a mature biofilm.
PL-biofilm Bacterial Viability
In the literature, themean bacterial viability in a 2-day PL-biofilm
oscillated between 60 and 77% (von Ohle et al., 2010; Gu et al.,
2012; García-Caballero et al., 2013; Prada-López et al., 2015a;
Quintas et al., 2015), the present series showed results in this
range (72 and 76% in both baseline situations, before CHX and
EO applications, respectively).
The mean bacterial viability after an Im-0.2% CHX ranged
from 0.7 to 35.16% in the previous scientific literature (Zaura-
Arite et al., 2001; Gosau et al., 2010; von Ohle et al., 2010). Such
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wide variations might be caused by the different methodologies
used in the studies. These differences mainly arise because of
a range of factors, such as the antiseptic concentration or the
time lapse of application. In their study on PL-biofilm, von
Ohle et al. (2010) chose a 0.1% CHX concentration and their
immersion times varied between 1 and 10min. This protocol
contrasts with that followed by Zaura-Arite et al. (2001) and
Gosau et al. (2010), who evaluated a commercial 0.2% CHX
concentration, and selected an immersion time lapse of 1min.
Despite the obvious methodological differences with other series
(time of exposure and concentration), the results of the present
study in terms of bacterial viability of the PL-biofilm after an
Im-0.2% CHX (approximately a 15%) are in accordance with
the results reported in the previous literature (Zaura-Arite et al.,
2001; Gosau et al., 2010; von Ohle et al., 2010). Respect to the
applied CHX protocol, the manufacturer recommendations in
terms of time of application were followed (30 s).
Regarding theMw-0.2% CHX, there are few evaluations of the
bacterial viability of the PL-biofilm after an active mouthwash
with this antiseptic (García-Caballero et al., 2013; Quintas et al.,
2015). In the present series, the bacterial viability was near to
5% which is consistent with that reported in previous studies
(García-Caballero et al., 2013; Quintas et al., 2015).
Concerning the mean bacterial viability after an Im-EO, the
results found in the literature ranged from 23 to 31% (Dong
et al., 2010; Gosau et al., 2010). In these cases, the antiseptic
concentration did not vary from one study to another. This is
probably one of the reasons why the range is narrower for the EO
than for the 0.2% CHX. Gosau et al. (2010) and Dong et al. (2010)
immersed a 12 and 48 h-PL-biofilm for 1min, respectively. The
present series showed amean bacterial viability within the named
range (approximately a 27%).
In regard to the assessment of the efficacy of an activeMw-EO,
to the best of the author’s knowledge, there is only one study in
which the bacterial viability of the PL-biofilm has been evaluated
(Quintas et al., 2015). This study showed a very low bacterial
viability 30 s after the Mw-EO, near to 1%, which is similar to
the present results.
Despite the visible lack of previous literature, the results
of the present series, in terms of bacterial viability, have a
clear interpretation, according to the authors: doing an active
mouthwash greatly reduces the bacterial viability of the PL-
biofilm, more so than doing an immersion with the same
antiseptic. When differentiating between 0.2% CHX and EO, we
found doing an Im-0.2% CHX was more effective than doing an
Im-EO.
On the other hand, when a mouthwash was done, the EO
solution was more effective than the 0.2% CHX. In previous
research of the authors (Quintas et al., 2015), the immediate effect
of the EO vs. 0.2%CHX has been already presented and discussed
in detail.
PL-biofilm Bacterial Viability by Layers
The distribution of the bacterial viability into the PL-biofilm in
the baseline disks was significantly lower in the deepest layers.
This distribution pattern of viability, in which vital bacteria
overlay non-vital bacteria, has been previously described in other
in vivo biofilm studies that analyzed bacterial viability in layers
(Arweiler et al., 2004; García-Caballero et al., 2013; Prada-López
et al., 2015a; Quintas et al., 2015).
After the Im-0.2% CHX, the bacterial viability decreased
significantly in all layers. However, there were no differences
among the layers (18% outer, 16% middle and 11% inner layer).
Zaura-Arite et al. (2001) analyzed the bacterial viability in the
different layers after a 1min immersion in 0.2% CHX showing its
efficacy as well, but with wide ranges of values (outer layer= 16–
42%, middle layer = 19–55% and inner layer = 21–58%). These
data were probably obtained due to the small sample size and the
characteristics of the volunteers (three heavy plaque-formers and
three light plaque-formers).
On the other hand, the Mw-0.2% CHX reduced the bacterial
viability similarly in all layers, being these findings in accordance
with those previously described in situ studies (García-Caballero
et al., 2013; Quintas et al., 2015). This reduction in bacterial
viability obtained by mouthwash, as recorded by layers, was
higher than the obtained from the immersion method.
In the present series, when applying the EO antiseptic, the
bacterial viability of the PL-biofilm was reduced in all layers after
the immersion. The outer layer showed significant less viability
than the other two (16% in the outer layer vs. 26% in the middle
and 39% in the deepest layer). In the same manner, Dong et al.
(2010), after a 1-min Im-EO found less bacterial viability in the
outer layer (outer layer = 22% vs. middle layer = 34%, and
inner layer = 37%). In both studies, a reduction in the bacterial
viability was shown, but a different spatial distribution in the
bacterial viability compared to their baselines could be seen
(Figure 5). While in the baseline sample the bacterial viability
decreased from the outer to the inner layers, after an Im-EO, this
distribution was inverted, showing an increase in the bacterial
viability from the outer to the inner layers. This fact could be
explained by the low capacity of the EO solution to penetrate
mature biofilms, resulting in a loss of efficacy in the deepest layers
of the PL-biofilm. In the contrast, this effect seen after the Im-EO
was completely lost after the Mw-EO. The EO applied following
the manufacturer’s instructions (a single mouthwash with 20mL
for 30 s) was clearly more effective in all layers than the simple
immersion, achieving bacterial viability results near to 0% in the
three layers.
The results of the present series confirmed that, to properly
assess the immediate antibacterial effect of 0.2% CHX and
EO, an in vivo active mouthwash following the manufacturer’s
recommendations should be done. This series has also shown that
an active mouthwash helped to maximize the efficacy of the 0.2%
CHX solution and, mainly, the EO solution compared to a single
immersion. In addition, the findings of this investigation suggest
cautious interpretation of the results of studies that followed an
ex vivo antiseptic application (immersion) in PL-biofilm. This
previous literature about antimicrobial activity of both 0.2%CHX
and EO relies on in vitro and in situ studies that do not follow
proper methodologies, pretending to equate a simple immersion
(ex vivo) with an active mouthwash (in vivo). To some extent,
this equation could be considered valid when isolated bacteria
are studied. However, when talking about bacteria associated in
a more complex structure such as a naturally-formed biofilm
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(that is 10–1000 times more resistant than bacteria in planktonic
phase) (Fine et al., 2001), something more than the simple
contact with the antiseptic is needed. This higher activity of
the antiseptic when applied as a mouthwash could be due to
the hydrodynamic forces that appear in the mouth thank to
the action of the tongue, cheeks and other muscles of the
oral cavity that contribute to the movement of the mouthwash
throughout all the surfaces of the mouth. This movement could
achieve something that the passive immersion could not, which
is breaking of the surface force of the PL-biofilm, being this
crucial for the antiseptic penetration. This is the same theory
followed in endodontics with the “hydrodynamic activation” of
the antiseptic in the interior of the radicular canal by agitation
(Weller et al., 1980; Peeters et al., 2014). This movement achieves
to break the surface force of small root canals contributing to
maximize the chemical action of the antiseptic (Peeters et al.,
2014).
Finally, the authors would like to point out another possible
differentiating variable which may condition the antiseptic
effectiveness: the temperature. In the ex vivo experiment, the
antiseptic was at room temperature (between 18 and 20◦C).
However, when the application was in vivo, the temperature
of the antiseptic solution rose by several degrees. In future
investigations, it would be interesting to study the role that
the temperature might play in the antimicrobial effect of the
antiseptic.
Conclusion
The method of application conditioned the antibacterial activity
of the 0.2% Chlorhexidine and the Essential Oils on the
plaque-like biofilm. The in vivo active mouthwash protocol
was more effective than the ex vivo passive immersion in both
antiseptic solutions, conditioning the obtained results. There
was more penetration of the antiseptic inside the biofilm with
an active mouthwash, especially when the Essential Oils were
used.
According to the results of the present study, future
investigations on oral antiseptics should take into account the
methodology of the application. To obtain a situation as close
as possible to the clinical reality, the plaque-like biofilm should
be formed in vivo. In addition, the antiseptic application should
be in situ, with an active mouthwash or, at least, take into
consideration the role that the movement of the solution may
have in the antiseptic antimicrobial activity.
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